A district court judge reversed course and sided with Ferring Pharmaceuticals Inc. in its suit against FDA demanding that the agency award its fixed-dose combination product Prepopik five years of market exclusivity.
In a Sept. 9 opinion, the US District Court for the District of Columbia Judge Rudolph Contreras concluded...








